IVDr portal banner small
1 - 4 sur 4
2 décembre 2016

Bruker Announces Corporate Partnership with International Phenome Centre Network (IPCN) for NMR Technologies and SOPs

28 juin 2016

Bruker Announces More Comprehensive and Efficient NMR Profiling Module for Detailed Lipoprotein Subclass Analysis in Cardiovascular Disease Research

4 septembre 2013

Bruker Announces Novel Approach for Inborn Errors of Metabolism (IEM) Screening by NMR

Clinical IEM-by-NMR Screening Study in Turkey Measures 65 Metabolites in Urine Simultaneously, Including 20 Endogeneous Metabolites and 45 Metabolites Associated with Inborn Errors of Metabolism

22 juillet 2013

Bruker Announces AVANCE™-IVDr as a Standardized NMR Platform for Clinical Screening and In Vitro Diagnostics (IVD) Discovery and Validation

New AVANCE-IVDr System Offers High Performance and Throughput for the Development and Validation of Emerging High-Quality, Information-Rich and Cost-Effective IVD-by-NMR and Clinical Screening Assays